## **Core Concept**
Ouabain, also known as digitalis, is a cardiac glycoside that acts on the heart to increase the force of contraction. It does so by affecting the ion balance within cardiac cells, specifically through its action on the sodium-potassium pump.

## **Why the Correct Answer is Right**
Ouabain exerts its effect by inhibiting the **Na+/K+-ATPase pump** (sodium-potassium pump) in the cardiac cell membrane. This pump normally uses ATP to transport sodium out of the cell and potassium into the cell, maintaining the cell's resting potential and proper ion balance. By inhibiting this pump, ouabain leads to an increase in intracellular sodium. This increase in sodium indirectly leads to an increase in intracellular calcium through the sodium-calcium exchanger, enhancing the contractility of the heart muscle.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because ouabain's primary mechanism is not related to blocking potassium channels.
- **Option B:** This option is incorrect as ouabain does not primarily act by stimulating adenylate cyclase; its action is more direct on the sodium-potassium pump.
- **Option C:** While calcium channels are crucial for cardiac contraction, ouabain does not directly inhibit L-type calcium channels; its effect on calcium levels is indirect.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the effects of ouabain (or digitalis) are highly dependent on its serum concentration. At therapeutic levels, it increases cardiac contractility and slows heart rate. However, at toxic levels, it can cause arrhythmias and other serious side effects. Monitoring its levels and the patient's response is crucial.

## **Correct Answer:** D. Na+/K+-ATPase pump.